Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Baricitinib Emergency use authorization Used to treat other disease Other treatment Feb/03/2022 33 2
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 69 5
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Jan/04/2022 16 1
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/04/2022 40 10
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 13
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Bosutinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Cobimetinib Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Sep/06/2021 2 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
Interferon beta Potential treatment - theoretical effect Used to treat other disease Antiviral May/12/2021 3 1